Umang Cure Private Limited, a active private limited company, was established on 03 September 1996 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U45201DL1996PTC081645. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
Formerly known as Umang Consfin Private Limited. It upholds a compliant status. Employing 350 professional, Its leadership includes Neelima Agarwal (Director), Umang Agarwal (Director). Past directors included Neelima Agarwal, Shiv Charan Agarwal, Alpana Agarwal. It holds no open charges and ₹4.90 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-213, Shanti Gopal Chamber, Vikas Marg, Shakarpur,, New Delhi, Delhi, 110092.
U45201DL1996PTC081645
081645
03 September 1996
₹5.00 M
₹5.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Umang Cure Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neelima Agarwal | Director | 18 Mar 2016 | Current |
| Umang Agarwal | Director | 14 Jul 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 17 Apr 2016 | Past |
| Pramod Abcsdd | Director | 14 Jul 2023 | Past |
| Pramod Abcsdd | Director | 14 Jul 2023 | Past |
| Pramod Abcsdd | Director | 27 Dec 2009 | Past |
| Pramod Abcsdd | Director | 31 Oct 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Umang Cure Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45.22% increase. The company also saw a substantial improvement in profitability, with a 63.61% increase in profit. The company's net worth Soared by an impressive increase of 27.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Umang Cure had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹49,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2016 | Others | ₹4.90 Cr | Satisfied |
Explore comprehensive loan charge details -
Umang Cure has a workforce of 350 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Umang Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Umang Cure's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Umang Cure Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Umang Cure Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity A charge registered on 29 Sep 2016 via Charge ID 100065196 with Others was fully satisfied on 22 Feb 2022. was completed.
A charge with Others amounted to Rs. 49.00 M with Charge ID 100065196 was registered on 29 Sep 2016. was recorded as a recent event.
The activity Neelima Agarwal was appointed as a Director was appointed as a Director on 18 Mar 2016 & has been associated with this company since 9 years 8 months . was completed.
The activity Umang Agarwal was appointed as a Director was appointed as a Director on 14 Jul 2014 & has been associated with this company since 11 years 4 months . was completed.
The CIN of Umang Cure Private Limited is U45201DL1996PTC081645.
Umang Cure Private Limited is headquartered at A-213, Shanti Gopal Chamber, Vikas Marg, Shakarpur,, New Delhi, Delhi, 110092.
Umang Cure Private Limited was incorporated on 03 September 1996.
The current directors of Umang Cure Private Limited are
The primary industry of Umang Cure Private Limited is Trade.
Umang Cure Private Limited is unlisted.
The authorized capital of Umang Cure Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Umang Cure Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX